Their research is the first where exosomes have been applied to target TKI-resistant cancers in Singapore. The findings were published in the journal Developmental Cell. Epidermal growth factor ...

its successful commercial development facilitated investigation of the drug's other kinase targets, KIT and platelet-derived growth factor receptor (PDGFR), in other neoplasms, including SCLC.

Investigator studied current treatment patterns and attrition rates in metastatic clear cell renal cell carcinoma using a large, US nationwide cohort.